Adage Capital Partners’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $54M | Sell |
|
|||||
|
2025
Q2 | $46.7M | Buy |
|
|||||
|
2025
Q1 | $5.6M | Sell |
|
|||||
|
2024
Q4 | $5.08M | Sell |
|
|||||
|
2024
Q3 | $47.2M | Sell |
|
|||||
|
2024
Q2 | $58.8M | Buy |
|
|||||
|
2024
Q1 | $41.1M | Buy |
|
|||||
|
2023
Q4 | $29.1M | Buy |
|
|||||
|
2023
Q3 | $22.7M | Sell |
|
|||||
|
2023
Q2 | $31.9M | Sell |
|
|||||
|
2023
Q1 | $64.8M | Sell |
|
|||||
|
2022
Q4 | $82.1M | Buy |
|
|||||
|
2022
Q3 | $6.69M | Sell |
|
|||||
|
2022
Q2 | $30M | Buy |
|
|||||
|
2022
Q1 | $26.9M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $14.3M | Hold |
|
|||||
|
2020
Q2 | $16.5M | Buy |
|
|||||
|
2020
Q1 | $5M | Buy |
|